Company Search:
Advanced Search
Sponsored Links
Medy-Tox Incorporation Company Snapshot
Medy-Tox Incorporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medy-Tox Incorporation with three other companies in this sector in South Korea: Samsung Biologics Co Ltd (2015 sales of 91.28 billion Korean Won [US$77.68 million] ), Hugel Inc (65.07 billion Korean Won [US$55.37 million] ), and Cell Biotech Co ., Limited. (49.50 billion Korean Won [US$42.13 million] of which 84% was Finished Products).

Sales Analysis. During the year ended December of 2015, sales at Medy-Tox Incorporation were 88.51 billion Korean Won (US$75.32 million). This is an increase of 16.6% versus 2014, when the company's sales were 75.89 billion Korean Won. This was the fifth consecutive year of sales increases at Medy-Tox Incorporation (and since 2010, sales have increased a total of 320%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medy-Tox Incorporation
  Stock Performance Chart for Medy-Tox Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 403,600
(Figures in Korean Won)
1 Week 6.8%   13 Weeks 15.8%  
4 Weeks -7.5%   52 Weeks -20.9%  
Medy-Tox Incorporation Key Data:
  Ticker: 086900 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 88,505,437,514
(Year Ending Jan 2016).
Employees: 280
  Currency: Korean Won Market Cap: 2,148,457,646,000
  Fiscal Yr Ends: December Shares Outstanding: 5,323,235
  Share Type: Common Closely Held Shares: 1,233,963
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.